Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 20, 2022, titled "Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement for commercializing Ryaltris Nasal Spray in for Singapore, Hong Kong and Vietnam".